Consensus on the treatment of dysphagia in Parkinson's disease

J Neurol Sci. 2021 Nov 15:430:120008. doi: 10.1016/j.jns.2021.120008. Epub 2021 Sep 27.

Abstract

Background: Dysphagia is common in Parkinson's disease (PD). The effects of antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia are available but there is no consensus on their efficacy in PD.

Objective: To conduct a systematic review of the literature and to define consensus statements on the treatment of dysphagia in PD and related nutritional management.

Methods: A multinational group of experts in the field of neurogenic dysphagia and/or Parkinson's disease conducted a systematic evaluation of the literature and reported the results according to PRISMA guidelines. The evidence from the retrieved studies was analyzed and discussed in a consensus conference organized in Pavia, Italy, and the consensus statements were drafted. The final version of statements was subsequently achieved by e-mail consensus.

Results: The literature review retrieved 64 papers on treatment and nutrition of patients with PD and dysphagia, mainly of Class IV quality. Based on the literature and expert opinion in cases where the evidence was limited or lacking, 26 statements were developed.

Conclusions: The statements developed by the Consensus panel provide a guidance for a multi-disciplinary treatment of dysphagia in patients with PD, involving neurologists, otorhinolaryngologists, gastroenterologists, phoniatricians, speech-language pathologists, dieticians, and clinical nutritionists.

Keywords: Consensus development conference; Deglutition disorders; Nutrition; Parkinson's disease; Rehabilitation.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Consensus
  • Deglutition Disorders* / etiology
  • Deglutition Disorders* / therapy
  • Humans
  • Italy
  • Parkinson Disease* / complications
  • Parkinson Disease* / therapy